Key points are not available for this paper at this time.
Answers are grounded in this paper and cite their sources.
Apoprotein removal does not alter hepatic chylomicron cholesterol uptake in rats; leaves open receptor mechanisms in human lipoprotein clearance.
Rat lymph chylomicrons were treated with Pronase resulting in particles completely devoid of surface apoproteins. On re-incubation with serum, the Pronase-treated chylomicrons re-acquired, by transfer from other lipoproteins, all apoproteins except apoprotein B, which is water-insoluble and non-transferable. When two groups of rats were injected with [3H]cholesterol-labelled control or Pronase-treated chylomicrons, radioactivity was incorporated into the liver of both groups at similar rates. It is concluded that the remnants of the control and Pronase-treated chylomicrons formed in the vascular space were recognized and taken up by liver cells by a process that does not require apoprotein B.
No takes yet. Share an insight, caveat, or question.
Borensztajn et al. (1982) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: